The Lions Health 2018 jury brought 10 senior communications executives together in Cannes, with representatives from China, Australia, UK, US, Brazil, Dubai, Ireland and Denmark.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh